1. Home
  2. RVPHW
  3. RVPHW News

Latest Reviva Pharmaceuticals Holdings Inc. (RVPHW) News on July 26, 2024

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

GlobeNewswire

17 days ago

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

Zacks Small Cap Research

2 months ago

RVPH: Enrollment Right Around the Corner

RVPH: Full Year 2023 Results

Zacks Small Cap Research

3 months ago

RVPH: Full Year 2023 Results

Associated Press Finance

6 months ago

AGNC Investment: Q4 Earnings Snapshot

TLSA: First Phase II SPMS Patient Dosed

Zacks Small Cap Research

7 months ago

TLSA: First Phase II SPMS Patient Dosed

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Remark Holdings Inc Earnings Call

Associated Press Finance

8 months ago

Remark Holdings: Q3 Earnings Snapshot

Associated Press Finance

9 months ago

FibroGen: Q3 Earnings Snapshot

Share on Social Networks: